Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bovine Ephemeral Fever Vaccine (MEVAC)
- Development stage
- Unknown
- Lead developer
- MEVAC
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Bovine Ephemeral Fever Vaccine (MEVAC) is an inactivated veterinary vaccine developed by Middle East for Vaccines (MEVAC) for the immunization of ruminants, particularly cattle, against Bovine Ephemeral Fever (BEF). BEF, also known as "three-day sickness," is an arthropod-borne viral disease caused by the Bovine Ephemeral Fever Virus (BEFV), a member of the Rhabdoviridae family. The disease is characterized by sudden high fever, lameness, joint pain, and a significant drop in milk production in dairy cattle. The vaccine is designed to stimulate the production of neutralizing antibodies against the virus, providing protective immunity and reducing the clinical severity and economic impact of outbreaks in livestock populations.
- Brand names
- MEVAC BEF
- Other names
- Bovine Ephemeral Fever VaccineBEF VaccineThree-Day Sickness Vaccine
Beyond the preview
Go deeper on Bovine Ephemeral Fever Vaccine (MEVAC).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bovine Ephemeral Fever Vaccine (MEVAC).